UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

The influence of various reef sounds on coral-fish larvae behaviour

Journal of fish biology, 2015-05, Vol.86 (5), p.1507-1518

2015

Volltextzugriff (PDF)

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Annals of oncology, 2003-01, Vol.14 (1), p.123-130

2003

Volltextzugriff (PDF)

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

European journal of nuclear medicine, 1998-09, Vol.25 (9), p.1244-1247

1998

Volltextzugriff (PDF)

Fluorinated tracers for imaging cancer with positron emission tomography

European journal of nuclear medicine and molecular imaging, 2004-08, Vol.31 (8), p.1182-1206

2004

Volltextzugriff (PDF)

Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis

Clinical cancer research, 2002-09, Vol.8 (9), p.2766-2774

2002

Volltextzugriff (PDF)

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

European Journal of Nuclear Medicine, 1996-12, Vol.23 (12), p.1641-1674

1996

Volltextzugriff (PDF)

Contribution of whole-body (18)FDG PET imaging in the management of cervical cancer

2002-10

Volltextzugriff (PDF)

In Vivo Imaging of Chemotherapy-Induced Apoptosis in Human Cancers

Annals of the New York Academy of Sciences, 2003-12, Vol.1010 (1), p.525-529

2003

Volltextzugriff (PDF)

F-18-FDG PET in children with lymphomas

2005-01

Volltextzugriff (PDF)

Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67

Nuclear medicine communications, 2002-08, Vol.23 (8), p.727-734

2002

Volltextzugriff (PDF)

Clinical added-value of 18fdg pet in neuroendocrine-merkel cell carcinoma

Oncology reports, 2006-08, Vol.16 (2), p.347-352

2006

Volltextzugriff (PDF)

Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)

Nuclear medicine communications, 2003-10, Vol.24 (10), p.1081-1086

2003

Volltextzugriff (PDF)

Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)

Cancer biotherapy & radiopharmaceuticals, 2001-08, Vol.16 (4), p.297-304

2001

Volltextzugriff (PDF)

Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography

Journal of the American College of Cardiology, 1990-04, Vol.15 (5), p.1021-1031

1990

Volltextzugriff (PDF)

Evaluation of pleural diseases with FDG-PET imaging: preliminary report

Thorax, 1997-02, Vol.52 (2), p.187-189

1997

Volltextzugriff (PDF)

Differential Diagnosis of Alzheimer's Disease with PET

The Journal of nuclear medicine (1978), 1994-03, Vol.35 (3), p.391-398

1994

Volltextzugriff (PDF)

Myocardial perfusion imaging with (99m)Tc tetrofosmin: Comparison to (201)Tl imaging and coronary angiography in a phase III multicenter trial

Circulation (New York, N.Y.), 1995-01, Vol.91 (2), p.313

1995

Volltextzugriff (PDF)

Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction

Heart (British Cardiac Society), 2001-11, Vol.86 (5), p.510-515

2001

Volltextzugriff (PDF)

Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography

European Journal of Nuclear Medicine, 1996-02, Vol.23 (2), p.204-206

1996

Volltextzugriff (PDF)

Technetium-99m-Tetrofosmin Myocardial Imaging: A Comparison with Thallium-201 and Angiography

The Journal of nuclear medicine (1978), 1994-04, Vol.35 (4), p.587-593

1994

Volltextzugriff (PDF)

Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis

Clinical cancer research, 2002-09, Vol.8 (9), p.2766-2774

2002

Volltextzugriff (PDF)

Staging of primary cervical cancers: the role of nuclear medicine

Critical reviews in oncology/hematology, 2003-06, Vol.46 (3), p.275-284

2003

Volltextzugriff (PDF)

Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity

European Journal of Nuclear Medicine, 1996-12, Vol.23 (12), p.1603-1612

1996

Volltextzugriff (PDF)

18F-FDG PET in children with lymphomas

European journal of nuclear medicine and molecular imaging, 2005-01, Vol.32 (1), p.31-38

2005

Volltextzugriff (PDF)

Characterization of Technetium-99m-L,L-ECD for Brain Perfusion Imaging, Part 2: Biodistribution and Brain Imaging in Humans

The Journal of nuclear medicine (1978), 1989-11, Vol.30 (11), p.1902-1910

1989

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Englisch
(207)
Französisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The influence of various reef sounds on coral-fish larvae behaviour

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

Fluorinated tracers for imaging cancer with positron emission tomography

Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

Contribution of whole-body (18)FDG PET imaging in the management of cervical cancer

In Vivo Imaging of Chemotherapy-Induced Apoptosis in Human Cancers

F-18-FDG PET in children with lymphomas

Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67

Clinical added-value of 18fdg pet in neuroendocrine-merkel cell carcinoma

Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)

Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)

Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography

Evaluation of pleural diseases with FDG-PET imaging: preliminary report

Differential Diagnosis of Alzheimer's Disease with PET

Myocardial perfusion imaging with (99m)Tc tetrofosmin: Comparison to (201)Tl imaging and coronary angiography in a phase III multicenter trial

Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction

Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography

Technetium-99m-Tetrofosmin Myocardial Imaging: A Comparison with Thallium-201 and Angiography

Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis

Staging of primary cervical cancers: the role of nuclear medicine

Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity

18F-FDG PET in children with lymphomas

Characterization of Technetium-99m-L,L-ECD for Brain Perfusion Imaging, Part 2: Biodistribution and Brain Imaging in Humans

Aktive Filter

Suchergebnisse filtern